Apoplogic Pharmaceuticals' Seed VC Round

Apoplogic Pharmaceuticals raised a round of funding on July 14, 2009.

ApopLogic Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development and commercialization of Breceptin, a unique oncolytic drug for the treatment of a wide range of soli…

Articles about Apoplogic Pharmaceuticals' Seed VC Round: